These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7092661)

  • 1. Plasma binding of fluorescein in normal subjects and in diabetic patients.
    Palestine AG; Brubaker RF
    Arch Ophthalmol; 1982 Jul; 100(7):1160-1. PubMed ID: 7092661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of fluorescein after intravenous administration.
    Chahal PS; Neal MJ; Kohner EM
    Invest Ophthalmol Vis Sci; 1985 May; 26(5):764-8. PubMed ID: 3997424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescein and fluorescein glucuronide in the vitreous body of diabetic patients.
    Lund-Andersen H; Larsen M; Dalgaard P; Olsen W
    Graefes Arch Clin Exp Ophthalmol; 1987; 225(3):173-6. PubMed ID: 3609757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescein distribution in retinas of normal and diabetic rats.
    Grimes PA
    Exp Eye Res; 1985 Aug; 41(2):227-38. PubMed ID: 4065247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of fluorescein and carboxyfluorescein by normal and glycosylated human serum proteins.
    Rockey JH; Li W
    Ophthalmic Res; 1982; 14(6):416-27. PubMed ID: 7162770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tritiated fluorescein binding to normal human plasma proteins.
    Ianacone DC; Felberg NT; Federman JL
    Arch Ophthalmol; 1980 Sep; 98(9):1643-5. PubMed ID: 7425929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescein binding to normal human serum proteins demonstrated by equilibrium dialysis.
    Li W; Rockey JH
    Arch Ophthalmol; 1982 Mar; 100(3):484-7. PubMed ID: 7065970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescein and fluorescein glucuronide pharmacokinetics after intravenous injection.
    Blair NP; Evans MA; Lesar TS; Zeimer RC
    Invest Ophthalmol Vis Sci; 1986 Jul; 27(7):1107-14. PubMed ID: 3721789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma fluorescein and fluorescein glucuronide in patients with selected eye diseases.
    Blair NP; Evans MA; Lesar TS; Willett M
    Graefes Arch Clin Exp Ophthalmol; 1989; 227(2):114-7. PubMed ID: 2721978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescein in human plasma in vitro.
    Lund-Andersen H; Krogsaa B
    Acta Ophthalmol (Copenh); 1982 Oct; 60(5):701-8. PubMed ID: 7164787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some aspects of the pharmacokinetics of fluorescein in normal and in diabetic subjects.
    Kjaergaard JJ; Dideriksen K; Mourits-Andersen T
    Int J Microcirc Clin Exp; 1983; 2(3):191-7. PubMed ID: 6678846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of fluorescein binding in human plasma using fluorescence polarization.
    Brubaker RF; Penniston JT; Grotte DA; Nagataki S
    Arch Ophthalmol; 1982 Apr; 100(4):625-30. PubMed ID: 7073582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The protein binding of some drugs in plasma from patients with alcoholic liver disease.
    Affrime M; Reidenberg MM
    Eur J Clin Pharmacol; 1975 Apr; 8(3-4):267-9. PubMed ID: 1233223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescein in human plasma in vivo.
    Lund-Andersen H; Krogsaa B; Jensen PK
    Acta Ophthalmol (Copenh); 1982 Oct; 60(5):709-16. PubMed ID: 7164788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of fluorescein and carboxyfluorescein by human serum proteins: significance of kinetic and equilibrium parameters of association in ocular fluorometric studies.
    Rockey JH; Li W; Eccleston JF
    Exp Eye Res; 1983 Nov; 37(5):455-66. PubMed ID: 6671474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular binding of fluorescein in lymphocytes.
    Meisingset KK; Steen HB
    Cytometry; 1981 Jan; 1(4):272-8. PubMed ID: 7261813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitreous fluorophotometry in patients with no or minimal diabetic retinopathy.
    Chahal P; Fallon TJ; Jennings SJ; Chowienczyk PJ; Kohner EM
    Diabetes Care; 1986; 9(2):134-9. PubMed ID: 3698779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A re-evaluation of pupillary sensitivity to autonomics in diabetic patients].
    Sugiyama T; Utsumi T; Miyashita Y; Moriya S; Suzuki M; Maetani S
    Nippon Ganka Gakkai Zasshi; 1990 Apr; 94(4):413-7. PubMed ID: 2396592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescent, physiological and pharmacokinetic properties of fluorescein glucuronide.
    Grotte D; Mattox V; Brubaker R
    Exp Eye Res; 1985 Jan; 40(1):23-33. PubMed ID: 3979458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular fluorophotometry in insulin-treated diabetic patients with and without retinopathy.
    Kjaergaard JJ; Ohrt V
    Int J Microcirc Clin Exp; 1983; 2(3):207-13. PubMed ID: 6381356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.